Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by Surgery

NCT00445861 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

BIOLOGICAL: cetuximab + docetaxel + cisplatin
BIOLOGICAL: Treatment level 1
BIOLOGICAL: Treatment level 2
PROCEDURE: conventional surgery

Sponsor

Swiss Cancer Institute